These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31278773)

  • 1. Biophysical and biological characterization of PEGylated recombinant human endostatin.
    Guo L; Xu B; Zhou D; Chang G; Fu Y; Liu L; Luo Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):920-927. PubMed ID: 31278773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin.
    Nie Y; Zhang X; Wang X; Chen J
    Bioconjug Chem; 2006; 17(4):995-9. PubMed ID: 16848407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.
    Wang S; Fu Y; Luo Y
    Chin J Cancer; 2016 Jan; 35():14. PubMed ID: 26792627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M
    Guo L; Geng X; Liu L; Miao Y; Lin Z; Yu M; Fu Y; Liu L; Li B; Luo Y
    J Biochem Mol Toxicol; 2019 Mar; 33(3):e22257. PubMed ID: 30536793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a monoPEG20000-Endostar.
    Tong Y; Zhong K; Tian H; Gao X; Xu X; Yin X; Yao W
    Int J Biol Macromol; 2010 Apr; 46(3):331-6. PubMed ID: 20122957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical Efficacy and Safety Pharmacology of PEGylated Recombinant Human Endostatin.
    Guo L; Hua L; Hu B; Wang J
    Curr Mol Med; 2024; 24(3):389-396. PubMed ID: 36999708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and characterization of mono PEGylated recombinant human interferon omega].
    Liu H; Cheng YG; Pan HC; Xu B; Peng L; Yang HT; Guo W
    Yao Xue Xue Bao; 2012 Mar; 47(3):393-8. PubMed ID: 22645765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.
    Huang Z; Ye C; Liu Z; Wang X; Chen H; Liu Y; Tang L; Zhao H; Wang J; Feng W; Li X
    Bioconjug Chem; 2012 Apr; 23(4):740-50. PubMed ID: 22433083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography.
    Qin X; Li J; Li Y; Gan Y; Huang H; Liang C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():206-213. PubMed ID: 28153672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
    Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
    Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel polyethylene glycol derivative suitable for the preparation of mono-PEGylated protein.
    Yun Q; Chen T; Zhang G; Bi J; Ma G; Su Z
    Biotechnol Lett; 2005 Feb; 27(3):213-7. PubMed ID: 15717132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys.
    Guo L; Li Z; Xu B; Yu M; Fu Y; Liu L; Wang J; Luo Y
    Life Sci; 2019 Dec; 238():116967. PubMed ID: 31626794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of exenatide analogue mono-PEGylated with 40 kDA polyethylene glycol by cation exchange chromatography.
    Cai Y; Yue P
    J Chromatogr A; 2011 Sep; 1218(39):6953-60. PubMed ID: 21862025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.
    Youngster S; Wang YS; Grace M; Bausch J; Bordens R; Wyss DF
    Curr Pharm Des; 2002; 8(24):2139-57. PubMed ID: 12369859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and purification of mono-PEGylated insulin.
    Dou H; Zhang M; Zhang Y; Yin C
    Chem Biol Drug Des; 2007 Feb; 69(2):132-8. PubMed ID: 17381727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
    Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
    J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography.
    Yun Q; Yang RE; Chen T; Bi J; Ma G; Su Z
    J Biotechnol; 2005 Jul; 118(1):67-74. PubMed ID: 15904987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity.
    Lee BK; Kwon JS; Kim HJ; Yamamoto S; Lee EK
    Bioconjug Chem; 2007; 18(6):1728-34. PubMed ID: 17941681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.